Enables ionotropic glutamate receptor binding activity; myosin V binding activity; and nuclear receptor binding activity. Involved in cellular response to calcium ion. Located in dendritic spine head; perikaryon; and perinuclear region of cytoplasm. Part of polysome. Human ortholog(s) of this gene implicated in amyotrophic lateral sclerosis; amyotrophic lateral sclerosis type 6; essential tremor 4; liposarcoma; and neurodegenerative disease. Orthologous to human FUS (FUS RNA binding protein); INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
16) in malignant liposarcoma); 16) malignant liposarcoma; fused in sarcoma; fusion (involved in t(12; fusion (involved in t(12,16) in malignant liposarcoma); fusion (involved in t(12,16) in malignant liposarcoma) (human); fusion, derived from t(12; fusion, derived from t(12,16) malignant liposarcoma; fusion, derived from t(12,16) malignant liposarcoma (human); fusion, derived from t(12;16) malignant liposarcoma; LOC317385; RNA-binding protein FUS
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FUS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FUS mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FUS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FUS mRNA
[NSC 689534 binds to Copper] which results in decreased expression of FUS mRNA, [Thiosemicarbazones binds to Copper] which results in increased expression of FUS protein
[NSC 689534 binds to Copper] which results in decreased expression of FUS mRNA, [Thiosemicarbazones binds to Copper] which results in increased expression of FUS protein
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FUS mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FUS mRNA
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUS mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FUS mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FUS mRNA
Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads.